Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jul;64(1):10–14. doi: 10.1038/bjc.1991.231

ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea.

Y Yura 1, M Azuma 1, K Uchida 1, H Momose 1, R Oyasu 1
PMCID: PMC1977327  PMID: 1854607

Abstract

We have established a reliable method to induce invasive and non-invasive carcinomas in the heterotopically transplanted urinary bladder of rats by repeated injection of N-methyl-N-nitrosourea (MNU), and examined the alterations of the ras oncogenes and ras oncogene product (p21) in the induced tumours. The incidence of muscle-invasive carcinomas was proportional to the total dose of MNU. When 5, 6 or 12 doses of MNU were used, muscle invasive carcinomas developed in 22, 58 or 45% of animals, respectively, after a mean observation period, respectively, of 54 +/- 9, 45 +/- 13 and 38 +/- 3 weeks. Whereas activated H-ras gene was detected in only one non-invasive carcinoma by DNA transfection assay, seven of 18 non-invasive and invasive carcinomas showed activated ras p21 when examined by immunoblot analysis. Amplification or rearrangement of myc or epidermal growth factor (EGF) receptor gene was not observed. The results indicate that alterations of ras gene may be involved in the development of rat bladder carcinomas but not of invasiveness.

Full text

PDF
10

Images in this article

12Figure 2
on p.12
12Figure 3
on p.12

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson P., Goldfarb M. P., Weinberg R. A. A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection. Cell. 1979 Jan;16(1):63–75. doi: 10.1016/0092-8674(79)90188-0. [DOI] [PubMed] [Google Scholar]
  2. Azuma M., Momose H., Oyasu R. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea. Cancer Res. 1990 Nov 1;50(21):7062–7067. [PubMed] [Google Scholar]
  3. Babaya K., Miyata Y., Chmiel J. S., Oyasu R. Effects of rat urine fractionated by molecular weight on urinary bladder carcinogenesis. Cancer Res. 1982 Jan;42(1):15–18. [PubMed] [Google Scholar]
  4. Bos J. L., Toksoz D., Marshall C. J., Verlaan-de Vries M., Veeneman G. H., van der Eb A. J., van Boom J. H., Janssen J. W., Steenvoorden A. C. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. 1985 Jun 27-Jul 3Nature. 315(6022):726–730. doi: 10.1038/315726a0. [DOI] [PubMed] [Google Scholar]
  5. Brawn P. N. The origin of invasive carcinoma of the bladder. Cancer. 1982 Aug 1;50(3):515–519. doi: 10.1002/1097-0142(19820801)50:3<515::aid-cncr2820500323>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  6. Carney W. P., Petit D., Hamer P., Der C. J., Finkel T., Cooper G. M., Lefebvre M., Mobtaker H., Delellis R., Tischler A. S. Monoclonal antibody specific for an activated RAS protein. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7485–7489. doi: 10.1073/pnas.83.19.7485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Debiec-Rychter M., Zukowski K., Wang C. Y. Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats. J Natl Cancer Inst. 1989 Mar 1;81(5):361–367. doi: 10.1093/jnci/81.5.361. [DOI] [PubMed] [Google Scholar]
  8. Finkel T., Der C. J., Cooper G. M. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell. 1984 May;37(1):151–158. doi: 10.1016/0092-8674(84)90310-6. [DOI] [PubMed] [Google Scholar]
  9. Fujita J., Srivastava S. K., Kraus M. H., Rhim J. S., Tronick S. R., Aaronson S. A. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3849–3853. doi: 10.1073/pnas.82.11.3849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fujita J., Yoshida O., Yuasa Y., Rhim J. S., Hatanaka M., Aaronson S. A. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. 1984 May 31-Jun 6Nature. 309(5967):464–466. doi: 10.1038/309464a0. [DOI] [PubMed] [Google Scholar]
  11. Furth M. E., Davis L. J., Fleurdelys B., Scolnick E. M. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol. 1982 Jul;43(1):294–304. doi: 10.1128/jvi.43.1.294-304.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hirao Y., Izumi K., Oyasu R. The effect of normal rat urine on mucosal regeneration in heterotopic urinary bladder. Lab Invest. 1980 Jan;42(1):76–84. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Meyers F. J., Gumerlock P. H., Kokoris S. P., deVere White R. W., McCormick F. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants. Cancer. 1989 Jun 1;63(11):2177–2181. doi: 10.1002/1097-0142(19890601)63:11<2177::aid-cncr2820631119>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  15. Oyasu R., Iwasaki T., Matsumoto M., Hirao Y., Tabuchi Y. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine. Cancer Res. 1978 Sep;38(9):3019–3025. [PubMed] [Google Scholar]
  16. Oyasu R., Manning D. J., Matsumoto M., Hopp M. L. Heterotopic urinary bladder with a communicating reservoir. Cancer Res. 1976 Jul;36(7 Pt 1):2261–2267. [PubMed] [Google Scholar]
  17. Oyasu R., Samma S., Ozono S., Bauer K., Wallemark C. B., Homma Y. Induction of high-grade, high-stage carcinomas in the rat urinary bladder. Cancer. 1987 Feb 1;59(3):451–458. doi: 10.1002/1097-0142(19870201)59:3<451::aid-cncr2820590317>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  18. Ozono S., Babaya K., Morikawa A., Oyasu R. A minimal dose of N-methyl-N-nitrosourea carcinogenic to heterotopically transplanted rat urinary bladder. Carcinogenesis. 1983;4(5):547–551. doi: 10.1093/carcin/4.5.547. [DOI] [PubMed] [Google Scholar]
  19. Pullano T. G., Sinn E., Carney W. P. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse. Oncogene. 1989 Aug;4(8):1003–1008. [PubMed] [Google Scholar]
  20. Reddy E. P., Reynolds R. K., Santos E., Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature. 1982 Nov 11;300(5888):149–152. doi: 10.1038/300149a0. [DOI] [PubMed] [Google Scholar]
  21. Seeburg P. H., Colby W. W., Capon D. J., Goeddel D. V., Levinson A. D. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature. 1984 Nov 1;312(5989):71–75. doi: 10.1038/312071a0. [DOI] [PubMed] [Google Scholar]
  22. Sukumar S., Notario V., Martin-Zanca D., Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 1983 Dec 15;306(5944):658–661. doi: 10.1038/306658a0. [DOI] [PubMed] [Google Scholar]
  23. Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanism of activation of a human oncogene. Nature. 1982 Nov 11;300(5888):143–149. doi: 10.1038/300143a0. [DOI] [PubMed] [Google Scholar]
  24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yuasa Y., Srivastava S. K., Dunn C. Y., Rhim J. S., Reddy E. P., Aaronson S. A. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature. 1983 Jun 30;303(5920):775–779. doi: 10.1038/303775a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES